Taiwan - Delayed Quote TWD

SCI Pharmtech, Inc. (4119.TW)

69.70
-0.60
(-0.85%)
As of May 27 at 1:30:19 PM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,574,151
1,523,738
1,204,159
899,738
864,217
Cost of Revenue
1,176,199
1,113,073
853,836
608,559
656,128
Gross Profit
397,952
410,665
350,323
291,179
208,089
Operating Expense
210,369
212,380
190,023
172,209
134,431
Operating Income
187,583
198,285
160,300
118,970
73,658
Net Non Operating Interest Income Expense
4,243
2,489
-2,843
-74
559
Pretax Income
630,441
646,857
364,190
387,820
65,506
Tax Provision
108,536
112,179
69,469
79,040
9,810
Net Income Common Stockholders
521,905
534,678
294,721
308,780
55,696
Diluted NI Available to Com Stockholders
521,905
534,678
294,721
308,780
55,696
Basic EPS
4.37
4.47
2.70
2.88
0.51
Diluted EPS
4.35
4.46
2.69
2.87
0.51
Basic Average Shares
118,820.54
119,509
109,309
107,305
108,997.62
Diluted Average Shares
120,394.74
119,953
109,609
107,593
109,206.74
Total Expenses
1,386,568
1,325,453
1,043,859
780,768
790,559
Net Income from Continuing & Discontinued Operation
521,905
534,678
294,721
308,780
55,696
Normalized Income
517,293.10
531,689.09
296,708.52
321,046.96
53,789.76
Interest Income
9,135
8,029
3,447
998
600
Interest Expense
4,892
5,540
6,290
1,072
41
Net Interest Income
4,243
2,489
-2,843
-74
559
EBIT
635,333
652,397
370,480
388,892
65,547
EBITDA
880,187
886,189
515,774
479,504
129,255
Reconciled Cost of Revenue
1,176,199
1,113,073
853,836
608,559
656,128
Reconciled Depreciation
244,854
233,792
145,294
90,612
63,708
Net Income from Continuing Operation Net Minority Interest
521,905
534,678
294,721
308,780
55,696
Total Unusual Items Excluding Goodwill
5,571
3,616
-2,456
-15,407
2,242
Total Unusual Items
5,571
3,616
-2,456
-15,407
2,242
Normalized EBITDA
874,616
882,573
518,230
494,911
127,013
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
959.10
627.09
-468.48
-3,140.04
335.76
12/31/2021 - 1/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
58.50
-0.51%
 
4108.TW PhytoHealth Corporation
15.15
-5.31%
 
1789.TW ScinoPharm Taiwan, Ltd.
17.35
-2.53%
 
4746.TW Formosa Laboratories, Inc.
70.50
+0.71%
 
4105.TWO TTY Biopharm Company Limited
75.60
+0.53%
 
3705.TW YungShin Global Holding Corporation
61.80
+0.65%
 
1731.TW Maywufa Company Ltd.
23.00
+0.22%
 
8432.TWO TSH Biopharm Corporation Limited
50.90
+0.59%
 
1707.TW Grape King Bio Ltd
133.50
-0.74%
 
4114.TWO Synmosa Biopharma Corporation
34.05
-0.15%